Skip to main content

For Healthcare Professionals

Site Menu

  • Press
  • About Us
  • Global Website
  • Contact
  • English

Search for product, molecule, disease…

User account menu

  • Log in
Home
  • Therapeutic Areas
    • CMR
  • Products
    • Jentadueto®
    • Trajenta®
  • Diseases
    • Diabetes
  • LogIn

Search for product, molecule, disease…

CAROLINA®

  1. Boehringer Ingelheim
  2. HCP Portal
  3. Products
  4. Trajenta®
  5. Resources
  6. CAROLINA®

CAROLINA®

Published 11.06.2019 by Boehringer Ingelheim

Explore the CAROLINA® trial, which evaluated more than 6,000 patients with relatively early T2D.

 

RELATED CONTENT

Trajenta global outcome program supporting cardiovascular and kidney safety profile
CVOT Overview

A comprehensive overview of the CVOT program.

CARMELINA assessed the cardiovascular and kidney safety profile of Trajenta
CARMELINA®

Dive deeper into the CARMELINA® trial.

Footer menu

  • Sitemap
  • Accessibility Statement
  • Terms of Use
  • Imprint
  • Cookie Policy
  • Privacy Policy
© 2022 Boehringer Ingelheim International GmbH. All rights reserved.
© 2022 Boehringer Ingelheim International GmbH.
All rights reserved.